ADDEX N/ CH0029850754 /
2024-08-28 5:30:01 PM | Chg. -0.0066 | Volume | Bid5:48:32 PM | Ask5:48:32 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
0.0700CHF | -8.62% | 3.58 mill. Turnover: 282,652.4682 |
0.0696Bid Size: 20,000 | 0.0808Ask Size: 20,000 | 12.48 mill.CHF | - | - |
GlobeNewswire
07-15
Addex Presents Positive Results from GABAB PAM Cough Program at the Thirteenth London International ...
GlobeNewswire
07-12
Addex To Present at the Thirteenth London International Cough Symposium (13th LICS)
GlobeNewswire
06-06
Addex Therapeutics Reports Q1 2024 Financial Results and Provides Corporate Update
GlobeNewswire
05-31
Addex Therapeutics to Release Q1 2024 Financial Results and Host Conference Call on June 6, 2024
GlobeNewswire
04-18
Addex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate Update
GlobeNewswire
04-11
Addex Therapeutics to Release Full-Year 2023 Financial Results and Host Conference Call on April 18,...
GlobeNewswire
04-03
Addex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Mod...
GlobeNewswire
01-31
Addex Enters into At-The-Market ADS Offering Agreement with H.C. Wainwright & Co. LLC.
GlobeNewswire
2023-11-23
Addex Therapeutics to Release Third Quarter 2023 Financial Results and Host Conference Call on Novem...